Data_Sheet_1_Risk Factors for Invasive Aspergillosis in Patients Admitted to the Intensive Care Unit With Coronavirus Disease 2019: A Multicenter Retrospective Study.docx
Background: Invasive pulmonary aspergillosis (IPA) is a life-threatening complication in coronavirus disease 2019 (COVID-19) patients admitted to intensive care units (ICUs), but risk factors for COVID-19-associated IPA (CAPA) have not been fully characterized. The aim of the current study was to identify factors associated with CAPA, and assess long-term mortality.
Methods: A retrospective cohort study of adult COVID-19 patients admitted to ICUs from six hospitals was conducted in Hubei, China. CAPA was diagnosed via composite clinical criteria. Demographic information, clinical variables, and 180-day outcomes after the diagnosis of CAPA were analyzed.
Results: Of 335 critically ill patients with COVID-19, 78 (23.3%) developed CAPA within a median of 20.5 days (range 13.0–42.0 days) after symptom onset. Compared to those without CAPA, CAPA patients were more likely to have thrombocytopenia (50 vs. 19.5%, p < 0.001) and secondary bacterial infection prior to being diagnosed with CAPA (15.4 vs. 6.2%, p = 0.013), and to receive vasopressors (37.2 vs. 8.6%, p < 0.001), higher steroid dosages (53.9 vs. 34.2%, p = 0.002), renal replacement therapy (37.2 vs. 13.6%, p < 0.001), and invasive mechanical ventilation (57.7 vs. 35.8%, p < 0.001). In multivariate analysis incorporating hazard ratios (HRs) and confidence intervals (CIs), thrombocytopenia (HR 1.98, 95% CI 1.16–3.37, p = 0.012), vasopressor use (HR 3.57, 95% CI 1.80–7.06, p < 0.001), and methylprednisolone use at a daily dose ≥ 40 mg (HR 1.69, 95% CI 1.02–2.79, p = 1.02–2.79) before CAPA diagnosis were independently associated with CAPA. Patients with CAPA had longer median ICU stays (17 days vs. 12 days, p = 0.007), and higher 180-day mortality (65.4 vs. 33.5%, p < 0.001) than those without CAPA.
Conclusions: Thrombocytopenia, vasopressor use, and corticosteroid treatment were significantly associated with increased risk of incident IPA in COVID-19 patients admitted to ICUs. The occurrence of CAPA may increase the likelihood of long-term COVID-19 mortality.
History
References
- https://doi.org//10.1038/nature20597
- https://doi.org//10.1186/s13054-020-03098-9
- https://doi.org//10.1093/infdis/jiab163
- https://doi.org//10.1164/rccm.202009-3400OC
- https://doi.org//10.2139/ssrn.3644400
- https://doi.org//10.1016/S1473-3099%2820%2930847-1
- https://doi.org//10.1016/S2213-2600%2820%2930079-5
- https://doi.org//10.1016/j.cmi.2020.07.010
- https://doi.org//10.1111/myc.13135
- https://doi.org//10.1164/rccm.202004-1038LE
- https://doi.org//10.1016/S2213-2600%2820%2930237-X
- https://doi.org//10.1093/cid/ciaa1065
- https://doi.org//10.1186/s13613-020-00686-4
- https://doi.org//10.1001/jama.2020.4683
- https://doi.org//10.1016/j.cmet.2021.01.002
- https://doi.org//10.1007/s00134-020-06022-5
- https://doi.org//10.1186/s13613-020-00689-1
- https://doi.org//10.1016/S2213-2600%2818%2930274-1
- https://doi.org//10.3389/fmed.2020.607821
- https://doi.org//10.1093/cid/ciab223
- https://doi.org//10.1186/s13054-020-03417-0
- https://doi.org//10.3390/jof5040090
- https://doi.org//10.1093/mmy/myx066
- https://doi.org//10.1093/mmy/myw102
- https://doi.org//10.1056/NEJMoa2021436
- https://doi.org//10.1111/myc.13185
- https://doi.org//10.1160/TH14-01-0074
- https://doi.org//10.3389/fimmu.2020.550827
- https://doi.org//10.1371/journal.ppat.1008544
- https://doi.org//10.1086/591458
- https://doi.org//10.1093/cid/ciz673
- https://doi.org//10.1111/myc.13096
Usage metrics
Read the peer-reviewed publication
Categories
- Radiology and Organ Imaging
- Foetal Development and Medicine
- Obstetrics and Gynaecology
- Primary Health Care
- Medical and Health Sciences not elsewhere classified
- Dermatology
- Emergency Medicine
- Gastroenterology and Hepatology
- Geriatrics and Gerontology
- Intensive Care
- Medical Genetics (excl. Cancer Genetics)
- Nephrology and Urology
- Nuclear Medicine
- Orthopaedics
- Otorhinolaryngology
- Pathology (excl. Oral Pathology)
- Family Care